The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyridine Single Therapy to the Oxaliplatin Regimen

被引:0
作者
Teranishi, Nobuhisa [1 ]
Uetake, Hiroyuki [1 ]
机构
[1] Natl Hosp Org NHO, Disaster Med Ctr, Dept Clin Res, 3256 Midori Cho, Tachikawa 1900014, Japan
关键词
colorectal cancer; adjuvant therapy in Japan; L-OHP; 5-FU + leucovorin; ACHIEVE trial; III COLON-CANCER; STAGE-II; SURVIVAL; FLUOROURACIL; LEUCOVORIN; TRIAL; S-1;
D O I
10.3390/cancers17030518
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effectiveness of oxaliplatin (L-OHP) has been reported overseas; however, in Japan, the prognosis of colorectal cancer (CRC) patients is reported to be good, and there has been a long debate about the applicability of L-OHP combination therapy in Japan. In recent years, the results of the ACHIEVE trial have become clear, and the standard consensus in Japan establishes L-OHP combination therapy for a duration of 3 months as the adjuvant treatment for CRC.
引用
收藏
页数:5
相关论文
共 32 条
[31]   Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study [J].
Gibbs, Peter ;
Gebski, Val ;
Van Buskirk, Mark ;
Thurston, Kenneth ;
Cade, David N. ;
Van Hazel, Guy A. .
BMC CANCER, 2014, 14
[32]   Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy [J].
Van Cutsem, Eric ;
Joulain, Florence ;
Hoff, Paulo M. ;
Mitchell, Edith ;
Ruff, Paul ;
Lakomy, Radek ;
Prausova, Jana ;
Moiseyenko, Vladimir M. ;
van Hazel, Guy ;
Cunningham, David ;
Arnold, Dirk ;
Schmoll, Hans-Joachim ;
ten Tije, Albert J. ;
McKendrick, Joseph ;
Kroening, Hendrik ;
Humblet, Yves ;
Gravalos, Cristina ;
Le-Guennec, Solenn ;
Andria, Michael ;
Dochy, Emmanuelle ;
Vishwanath, Raghu L. ;
Macarulla, Teresa ;
Tabernero, Josep .
TARGETED ONCOLOGY, 2016, 11 (03) :383-400